Home » Patient Assistance

Patient Assistance

PAN Foundation

Applicable to patients in the United States only

In May 2022, TSF announced its partnership with The PAN Foundation to help people living with neuromyelitis optica spectrum disorder (NMOSD), providing up to $9,600 per year in financial assistance and support services for patients and their caregivers or loved ones.

The Assistance Fund (TAF)

Applicable to patients in the United States only

In August 2022, TSF announced its partnership with The Assistance Fund to help people living in the US with neuromyelitis optica spectrum disorder (NMOSD) by providing financial assistance and support services for patients and their caregivers or loved ones.

The program provides financial assistance with the following out-of-pocket costs:

• Prescription drug assistance (copays, deductibles, and coinsurance) on FDA-approved treatment
• Health insurance premiums
• Therapy administration costs  
• Disease management, such as prescribing physician copayments  
• Treatment-related travel costs
• Diagnostic laboratory tests

National Organization for Rare Disorders (NORD)

Applicable to patients in the United States only

NORD’s Neuromyelitis Optica Spectrum Disorder (NMOSD) Patient Assistance Program is open and accepting applications for assistance. This program is designed to lessen the financial burden that may accompany having a rare diagnosis. To learn more, click the link below, email [email protected] and/or call (203) 202-8833